Withholding Feeds During Red Blood Cell Transfusion and TRAGI

NCT ID: NCT02132819

Last Updated: 2014-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Necrotising enterocolitis (NEC) is a devastating picture that all the neonatologists are afraid of facing during the follow up of newborns. During the last years, investigators ran retrospective observational studies abut NEC developing within the 48 hours after red blood cell transfusion. In the previous studies, the incidence of transfusion associated NEC (TANEC) was found to be 20-35%.Multiple transfusions potentially cause an increased risk for retinopathy of prematurity (ROP) and NEC. Investigators have also proposed a hypothesis about transfusion related acute gut injury (TRAGI), an adverse reaction of transfusion, similar to transfusion related acute lung injury (TRALI) seen in adults.In most of the neonatology clinics, withholding feeds during transfusion is not preferred. But several recent studies show an increase in the incidence of TANEC if the newborn goes on feeding before, during and after the transfusion process, especially if it is fed with a formula. The main aim of this study is to investigate the effect of withholding feeds during transfusion, on the development of TRAGI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transfusion Feeding During Transfusion Transfusion Related Acute Gut Injury Necrotising Enterocolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Feeding During Transfusion

The feeding process will be continued during the transfusion

Group Type PLACEBO_COMPARATOR

feeding during transfusion

Intervention Type OTHER

The feeding process will be continued during the transfusion

witholding feeds

At least 2 feeds before the transfusion, 2 feeds after the transfusion and feeds during the transfusion are withholded

Group Type ACTIVE_COMPARATOR

Withholding feeds

Intervention Type OTHER

At least 2 feeds before the transfusion, 2 feeds after the transfusion and feeds during the transfusion are withholded

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Withholding feeds

At least 2 feeds before the transfusion, 2 feeds after the transfusion and feeds during the transfusion are withholded

Intervention Type OTHER

feeding during transfusion

The feeding process will be continued during the transfusion

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \<32 weeks of gestational age or \<1500 gr, \>7 days old premature babies.
* Babies which are fed enterally well at the time of tha planning of transfusion.

Exclusion Criteria

* Babies with severe sepsis signs.
* Babies with severe hypoxia and asphyxia.
* Babies with congenital anomaly or complex cardiac anomaly.
Minimum Eligible Age

7 Days

Maximum Eligible Age

3 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zekai Tahir Burak Women's Health Research and Education Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Suzan Sahin

Fellow in Neonatology, Pediatrician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suzan Sahin, MD

Role: PRINCIPAL_INVESTIGATOR

Zekai Tahir Burak Women's Health Research and Education Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Suzan Sahin

Ankara, Altındag, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Suzan Sahin, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Suzan Sahin, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sahin1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transfusion of Prematures Trial
NCT01702805 COMPLETED NA